DK1448993T3 - Detektering af autoantistoffer reaktive med antigene molekyler af pankreas-öceller - Google Patents

Detektering af autoantistoffer reaktive med antigene molekyler af pankreas-öceller

Info

Publication number
DK1448993T3
DK1448993T3 DK02779738T DK02779738T DK1448993T3 DK 1448993 T3 DK1448993 T3 DK 1448993T3 DK 02779738 T DK02779738 T DK 02779738T DK 02779738 T DK02779738 T DK 02779738T DK 1448993 T3 DK1448993 T3 DK 1448993T3
Authority
DK
Denmark
Prior art keywords
pancreatic islet
antigenic molecules
detection
antigenic
islet cells
Prior art date
Application number
DK02779738T
Other languages
English (en)
Inventor
Bernard Rees Smith
Jadwiga Furmaniak
Michael Powell
Original Assignee
Rsr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9926667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1448993(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rsr Ltd filed Critical Rsr Ltd
Application granted granted Critical
Publication of DK1448993T3 publication Critical patent/DK1448993T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01048—Fusarinine-C ornithinesterase (3.1.1.48)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
    • C12Y301/03048—Protein-tyrosine-phosphatase (3.1.3.48)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y401/00—Carbon-carbon lyases (4.1)
    • C12Y401/01—Carboxy-lyases (4.1.1)
    • C12Y401/01015—Glutamate decarboxylase (4.1.1.15)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/988—Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02779738T 2001-11-28 2002-11-26 Detektering af autoantistoffer reaktive med antigene molekyler af pankreas-öceller DK1448993T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0128583.2A GB0128583D0 (en) 2001-11-28 2001-11-28 Detection of autoantibodies indicative of diabetes
PCT/GB2002/005285 WO2003048772A2 (en) 2001-11-28 2002-11-26 DETECTION OF REACTIVE AUTOANTICORPS WITH ANTIGENIC MOLECULES OF PANCREATIC ISLANDS AND / OR INSULIN

Publications (1)

Publication Number Publication Date
DK1448993T3 true DK1448993T3 (da) 2009-06-22

Family

ID=9926667

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02779738T DK1448993T3 (da) 2001-11-28 2002-11-26 Detektering af autoantistoffer reaktive med antigene molekyler af pankreas-öceller

Country Status (11)

Country Link
US (4) US8129132B2 (da)
EP (1) EP1448993B1 (da)
JP (2) JP2005512056A (da)
CN (1) CN100439920C (da)
AT (1) ATE426166T1 (da)
AU (1) AU2002343076A1 (da)
DE (1) DE60231639D1 (da)
DK (1) DK1448993T3 (da)
ES (1) ES2320427T3 (da)
GB (1) GB0128583D0 (da)
WO (1) WO2003048772A2 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0128583D0 (en) * 2001-11-28 2002-01-23 Rsr Ltd Detection of autoantibodies indicative of diabetes
US7131202B2 (en) * 2004-03-11 2006-11-07 The Gillette Company Cutting members for shaving razors with multiple blades
GB2426581A (en) * 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
JP2011106644A (ja) 2009-10-22 2011-06-02 Honda Motor Co Ltd 変速機の油圧制御装置
ES2677844T3 (es) 2010-10-19 2018-08-07 The Regents Of The University Of Colorado, A Body Corporate Péptidos para modular la actividad de linfocitos T y usos de los mismos
EP2631653A1 (en) * 2012-02-24 2013-08-28 Charité - Universitätsmedizin Berlin Identification of modulators of binding properties of antibodies reactive with a member of the insulin receptor family
CN102967704B (zh) * 2012-11-26 2014-05-14 深圳市伯劳特生物制品有限公司 一种用于糖尿病自身抗体6项联检试剂盒
JP6196989B2 (ja) * 2013-02-05 2017-09-13 シスメックス株式会社 １型糖尿病の早期診断マーカーであるｇａｄ抗体の高感度測定方法
CN104098670A (zh) * 2013-04-03 2014-10-15 苏州偲聚生物材料有限公司 多肽、包含该多肽的检测器件和检测试剂盒
CN104098677A (zh) * 2013-04-03 2014-10-15 苏州偲聚生物材料有限公司 多肽、包含该多肽的检测器件和检测试剂盒
CN104560911B (zh) * 2014-12-18 2018-06-05 深圳市新产业生物医学工程股份有限公司 一种融合抗原蛋白质
CN104569425B (zh) * 2014-12-18 2017-02-08 深圳市新产业生物医学工程股份有限公司 一种与酪氨酸磷酸酶抗体特异结合的抗原蛋白质
CN107044977A (zh) * 2016-06-30 2017-08-15 深圳市亚辉龙生物科技股份有限公司 一种酪氨酸磷酸酶抗体化学发光免疫检测试剂盒及其制备方法
US11793854B2 (en) 2019-03-21 2023-10-24 Op-T Llc Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD150 interaction
WO2020210726A1 (en) * 2019-04-12 2020-10-15 Op-T Llc Diagnosis and treatment of autoimmune diseases
EP4135742A2 (en) 2020-04-17 2023-02-22 Op-T Llc Bioactive peptides and methods of use thereof
CN112710839A (zh) * 2020-12-14 2021-04-27 三诺生物传感股份有限公司 一种gad65自身抗体检测试剂盒及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0366673B1 (en) * 1987-06-09 1992-09-16 Cambridge Life Sciences Plc Immunoassay method
CN1036080A (zh) * 1988-03-23 1989-10-04 广东省肇庆地区第一人民医院 表面抗原的快速检测法
WO1993010146A1 (en) 1991-11-19 1993-05-27 Amylin Pharmaceuticals, Inc. Amylin agonist peptides and uses therefor
AU675416B2 (en) * 1991-11-01 1997-02-06 Joslin Diabetes Center Antigen associated with type I diabetes mellitus
US5200318A (en) 1992-05-13 1993-04-06 Miles Inc. Diagnosis of IDDM with a panel of immunoreagents
JP4242446B2 (ja) * 1992-12-03 2009-03-25 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 糖尿病及びスティフマン症候群の診断及び治療用改良試薬及び方法
CN1053276C (zh) * 1997-03-11 2000-06-07 中日友好医院 一种检测胰岛细胞抗体的方法
DE19723463A1 (de) * 1997-06-04 1998-12-10 Dade Behring Marburg Gmbh Immunchemische Bestimmung von multivalenten Analyten
GB9719357D0 (en) 1997-09-11 1997-11-12 Ortho Clinical Diagnostics Immunoassay Utilizing Two Incubations With Labelled Antigen
US6187563B1 (en) * 1998-08-07 2001-02-13 Yale University βIV-spectrin-polypeptides and nucleic acids encoding same
CN1283794A (zh) * 2000-07-12 2001-02-14 华西医科大学 同步快速测定多项免疫指标技术
GB0128583D0 (en) * 2001-11-28 2002-01-23 Rsr Ltd Detection of autoantibodies indicative of diabetes

Also Published As

Publication number Publication date
ATE426166T1 (de) 2009-04-15
CN1585900A (zh) 2005-02-23
WO2003048772A2 (en) 2003-06-12
US20160356771A1 (en) 2016-12-08
US9435797B2 (en) 2016-09-06
US20050019837A1 (en) 2005-01-27
US20160356772A1 (en) 2016-12-08
JP5711449B2 (ja) 2015-04-30
EP1448993B1 (en) 2009-03-18
JP2005512056A (ja) 2005-04-28
AU2002343076A1 (en) 2003-06-17
US20120225955A1 (en) 2012-09-06
EP1448993A2 (en) 2004-08-25
CN100439920C (zh) 2008-12-03
US10481156B2 (en) 2019-11-19
ES2320427T3 (es) 2009-05-22
GB0128583D0 (en) 2002-01-23
WO2003048772A3 (en) 2003-10-16
JP2009265109A (ja) 2009-11-12
US8129132B2 (en) 2012-03-06
US10488410B2 (en) 2019-11-26
DE60231639D1 (de) 2009-04-30

Similar Documents

Publication Publication Date Title
DK1448993T3 (da) Detektering af autoantistoffer reaktive med antigene molekyler af pankreas-öceller
FROST et al. Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts
Andersson et al. Isolation of phosphoproteins by immobilized metal (Fe3+) affinity chromatography
Hantgan et al. Pathways of folding of reduced bovine pancreatic ribonuclease
Tomohiro et al. Cross‐linking chemistry and biology: development of multifunctional photoaffinity probes
Hermansson et al. MS analysis of rheumatoid arthritic synovial tissue identifies specific citrullination sites on fibrinogen
Toyo'oka et al. Simultaneous determination of thiols and disulfides by high-performance liquid chromatography with fluorescence detection
DK1092155T3 (da) Fremgangsmåde til tidlig diagnose af carcinomer
AU3062300A (en) Methods for detecting changes to cellular components
van den Born et al. No change in glomerular heparan sulfate structure in early human and experimental diabetic nephropathy
ES2103136T3 (es) Kit de ensayo.
Wallace et al. New conducting polymer affinity chromatography stationary phases
Lockshin et al. Hydrodynamic behavior of human and bacterial thymidylate synthetases and thymidylate synthetase-5-fluoro-2'-deoxyuridylate-5, 10-methylenetetrahydrofolate complexes. Evidence for large conformational changes during catalysis
WO2001075449A1 (fr) Technique d'investigation du cancer par epreuve biologique d'un autoanticorps contre mdm2 et reactif
EA200500253A1 (ru) Способ поиска лекарственного вещества
Ihling et al. Nano‐high‐performance liquid chromatography in combination with nano‐electrospray ionization Fourier transform ion‐cyclotron resonance mass spectrometry for proteome analysis
HUP9904222A2 (hu) Eljárás p53 elleni antitestek kimutatására
GB2358019A (en) Non-hydrolyzable analogs of heroin metabolites suitable for use in immunoassay
ATE427494T1 (de) Verfahren zur quantifizierung der akt-protein- expression
Vacik et al. Separation and measurement of isoenzymes and other proteins by high-performance liquid chromatography
Wang et al. Simultaneous monitoring of quantum dots and their assembly and disassembly with PreScission protease using capillary electrophoresis with fluorescence detection
Capasso et al. Effect of lysine residues on the deamidation reaction of asparagine side chains
Gong et al. Schistosoma japonicum antibody assay by immunosensing with fluorescence detection using 3, 3′, 5, 5′-tetramethylbenzidine as substrate
CO5300499A1 (es) Ensayo de inmunoabsorbente ligado a enzima de inhibicion (elisa) para deteccion y cuantificacion de anticuerpos en muestras biologicas
GB0323231D0 (en) Immunodiffusion assays